Improve thinking with scalp stimulation
- Trial ID
- NCT05808504
- Official Title
- Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
- Goal
- Improve thinking with scalp stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Study Type
- INTERVENTIONAL
- Enrollment
- 90 participants
- Conditions
- Parkinson Disease
- Interventions
- Neuropsychological assessment, Neurological assessment, Cognitive task, EEG, tACS (real or sham)
Plain-Language Summary
The trial is testing whether non-invasive alternating electrical stimulation can improve cognitive symptoms in Parkinson's, by targeting the brain rhythms that support attention and memory. Participants receive transcranial alternating current stimulation, either real or sham, while researchers record EEG and run cognitive tasks, the weak scalp currents aim to nudge or re-synchronize neural oscillations and are used as an add-on rather than replacing levodopa or other meds. They are recruiting adults 18 to 75 with idiopathic Parkinson's and reasonably preserved cognition (MoCA 22 or higher), no deep brain stimulation, and no major other neurological or psychiatric disorders, with healthy adults included as controls.
Locations
- CHU de Rennes, Rennes, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Neuropsychological assessment. The trial is testing whether non-invasive alternating electrical stimulation can improve cognitive symptoms in Parkinson's, by targeting the brain rhythms that support attention and memory. Participants receive transcranial alternating current stimulation, either real or sham, while researchers record EEG and run cognitive tasks, the weak scalp currents aim to nudge or re-synchronize neural oscillations and are used as an add-on rather than replacing levodopa or other meds. They are recruiting adults 18 to 75 with idiopathic Parkinson's and reasonably preserved cognition (MoCA 22 or higher), no deep brain stimulation, and no major other neurological or psychiatric disorders, with healthy adults included as controls.
- Who can participate?
- Participants must be between 18 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 8 months.